Business Wire

MI-EATON-VEHICLE-GROUP

21.4.2022 12:32:13 CEST | Business Wire | Press release

Share
Eaton’s Vehicle Group Facilities Reducing Environmental Impact With New Technologies and Systems

Power management company Eaton today announced its Vehicle Group has certified 88% of its global facilities as “zero-waste-to-landfill” (ZWTL), having cut the amount of waste going into landfills by 55% since 2019. Eaton defines ZWTL as consistently achieving a landfill waste diversion rate of 98% through reuse, composting, recycling or incineration, but only if the heat generated by incineration was collected and used to create more energy than what was used in the incineration process.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220421005050/en/

“We are extremely proud of how we’ve come together to upgrade our manufacturing facilities, leveraging technology to improve energy efficiency, minimize environmental impact and bring us closer to a carbon-free future,” said Sunil Bhandari, vice president, Global Operations, Eaton’s Vehicle Group. “Our commitment to sustainability is part of our core mission to improve the quality of life and the environment for those who count on us today and in the decades to come.”

To reduce waste, the Vehicle Group is focused on four primary areas: reuse, recycle, waste to energy and waste to landfill.

Separating swarf from water and recycling keeps it from landfill

One of the key projects in these efforts is the Vehicle Group’s swarf grinding project, which is in the process of being implemented at all its global sites that perform grinding operations.

Swarf is a byproduct generated during metal-cutting processes when fluids such as oils, coolants and water are mixed with fine particles of metal and filtration media. Swarf is one of the most difficult waste streams to recycle, but the Vehicle Group has made great strides in diverting swarf waste from landfills.

Through vendor partnerships, the Vehicle Group deploys a mobile centrifuge process that separates the materials. The fluid then is reused in manufacturing processes, and the metal particles are recycled, resulting in cost savings. A swarf recycling trial in 2019 diverted 500 tons from the landfill, and work is ongoing to expand this solution to expedite ZWTL progress.

The Vehicle Group is finding reuse opportunities to eliminate sludge created during the plating process by recycling the metal content, which eliminates the need for disposal into a landfill. It is also working to develop a more efficient filtering process to remove sludge and reuse the water for further plating.

Additionally, significant progress is being made in the segregation of general trash. Trash is typically created from a lack of knowledge of recycling opportunities and the use of unrecyclable materials. In an effort to prevent paper, metal and recyclable plastics from going into the trash, the Vehicle Group is working to improve education around recycling opportunities and procedures. Along these same lines, the Vehicle Group is ensuring all packaging it uses is recyclable and is encouraging its suppliers to do the same.

“For these efforts to realize their full potential, we are educating our teams on correct recycling methods, and we are asking for input on how to identify issues and new areas of opportunity,” Bhandari said.

Water conservation efforts making a significant impact at global sites

Implementing several innovative initiatives, the Vehicle Group has lowered water consumption at its global sites by 14% since 2019, putting it well on its way to achieving its 2030 zero water discharge target.

To reduce water consumption and mitigate pollutants, the Vehicle Group is installing wastewater systems featuring ultrafiltration and reverse osmosis technologies at several of its facilities. The systems treat and reuse water for industrial purposes. Some facilities are also managing stormwater by increasing the permeability of their property, decreasing runoff rates to reduce erosion and planting native florae that don’t require watering. Additionally, automatic flow-sensor faucets are being installed at Vehicle Group global facilities to enable the reuse of chiller water used during daily operations.

Read more about Eaton’s commitment to sustainability in its latest Sustainability Report.

Learn more about how Eaton is helping its customers conserve resources and reduce their carbon footprint.

Eaton is an intelligent power management company dedicated to improving the quality of life and protecting the environment for people everywhere. We are guided by our commitment to do business right, to operate sustainably and to help our customers manage power — today and well into the future. By capitalizing on the global growth trends of electrification and digitalization, we’re accelerating the planet’s transition to renewable energy, helping to solve the world’s most urgent power management challenges, and doing what’s best for our stakeholders and all of society.

Founded in 1911, Eaton has been listed on the NYSE for nearly a century. We reported revenues of $19.6 billion in 2021 and serve customers in more than 170 countries. For more information, visit www.eaton.com . Follow us on Twitter and LinkedIn.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Organon to Present New Research on Access and Value at ISPOR 202615.5.2026 13:30:00 CEST | Press release

New findings will highlight contraception affordability, biosimilar adoption, and access-focused analyses across the women’s health and general medicines portfolio Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, will present data across women’s health, biosimilars, dermatology, and neurology at ISPOR 2026, the leading global scientific conference hosted by the International Society for Pharmacoeconomics and Outcomes Research. The conference, focused on health economics and outcomes research, will take place May 17-20, 2026, in Philadelphia, Pennsylvania. Across 8 accepted abstracts, the data reflect Organon’s commitment to generating real-world evidence—rooted in lived experiences—that can help inform healthcare decision-making and improve health outcomes across a range of therapeutic areas. “Health economics and outcomes research is critical to ensuring the right treatments reach patients and that

SES Announces Extraordinary General Meeting of Shareholders15.5.2026 08:30:00 CEST | Press release

SES: Société Anonyme RCS Luxembourg B 81267 Notice is hereby given of the Extraordinary General Meeting of SES, Société Anonyme, to be held at the Company's registered office at Château de Betzdorf, L-6815 Betzdorf (the "Company"), Luxembourg, on Wednesday 17 June 2026 at 3:00 p.m. CET AGENDA Attendance list, quorum and adoption of the agenda Nomination of a secretary and of two scrutineers Cancellation of shares purchased in connection with the buy-back programme of 2 November 2023, as amended on 2 May 2024, in accordance therewith and pursuant thereto - Reduction of the share capital in accordance with article 450-5 of the law of 10 August 1915 on commercial companies, as amended, by forty-four million nine hundred ten thousand seven hundred eighty euro (EUR 44,910,780) through the cancellation of thirty-five million nine hundred and twenty-eight thousand six hundred and twenty-four (35,928,624) shares divided into (i) twenty-three million nine hundred and fifty-two thousand four hun

Experian Partners With ServiceNow to Scale Trusted Decisioning to Agentic AI15.5.2026 08:00:00 CEST | Press release

New global long‑term partnership embeds Experian’s Ascend capabilities directly into ServiceNow workflows, transforming client operations Experian, the global data and technology company, and ServiceNow (NYSE: NOW), the AI control tower for business reinvention, today unveil a new global multi-year partnership which harnesses the power of autonomous AI agents across platforms, helping businesses make faster and smarter decisions at scale. Through this partnership, autonomous AI agents can gain the ability to act faster, and more consistently, starting with employee onboarding, third-party risk management and model life cycle governance use cases. A major challenge for global organisations adopting agentic AI is achieving scale, with deployments often constrained by a lack of trusted data. In fact, industry research shows that data limitations are the primary barrier for eight in ten organisations. By connecting trusted intelligence directly into enterprise workflows, this partnership e

Meiji Seika Pharma: Positive Results from the Phase III Integral-1 Trial of Nacubactam, a Novel β-Lactamase Inhibitor, in Complicated Urinary Tract Infections or Acute Uncomplicated Pyelonephritis ― Published in The Lancet15.5.2026 03:00:00 CEST | Press release

Meiji Seika Pharma Co., Ltd. (headquartered in Tokyo; President and Representative Director: Toshiaki Nagasato) today announced that the results of the Integral-1 study, one of two global Phase III clinical trials evaluating the efficacy and safety of its novel β-lactamase inhibitor nacubactam (development code: OP0595), have been published in The Lancet. The article is entitled “---Efficacy and safety of cefepime–nacubactam and aztreonam–nacubactam compared with imipenem–cilastatin for complicated urinary tract infection or acute uncomplicated pyelonephritis (Integral-1): a double-blind, randomised phase 3 trial” (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00596-9/fulltext) Integral-1 is a global, double-blind, randomized Phase III trial (jRCT2031230075) in patients with complicated urinary tract infection or acute uncomplicated pyelonephritis that compared the efficacy and safety of nacubactam co-administered with either cefepime or aztreonam versus imipenem-c

Boomi Teams up With Gong to Bring Revenue AI to Boomi Agentstudio14.5.2026 18:00:00 CEST | Press release

Gong's revenue AI is now natively available in the Boomi Enterprise Platform Boomi, the data activation company for AI, today announced a collaboration withGong, the leader in Revenue AI, to bring revenue signals captured in Gong natively into the Boomi Enterprise Platform. This collaboration enables enterprises to establish an active data foundation designed to transform customer conversations into coordinated, automated actions across systems and functions enterprise-wide with Boomi Agentstudio. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260514443012/en/ Boomi Teams Up with Gong to Bring Revenue AI to Boomi Agentstudio Gong goes beyond capturing deal activity to surface real-time insights into risk, buyer intent, competitive dynamics, and key engagement signals. That intelligence moves from conversation to coordinated action, flowing across CRM, ERP, product, and operational systems with the governance and security tha

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye